TELOSAF TRIO 6.25 TABLET

Product Description

TELOSAF TRIO 6.25 TABLET | Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Smart Triple Action for Effective Blood Pressure Control

TELOSAF TRIO 6.25 TABLET is a scientifically balanced antihypertensive solution that combines Telmisartan, Cilnidipine, and Chlorthalidone to deliver broad-spectrum blood pressure management. This triple therapy addresses hypertension through complementary pathwaysvasodilation, angiotensin receptor blockade, and mild diuretic actionensuring effective and sustained control.

Key Benefits:

• Targets high blood pressure with a triple-mechanism approach

• Ideal for patients needing mild diuretic support (6.25mg Chlorthalidone)

• Reduces cardiovascular risk while supporting kidney protection

• Promotes patient compliance with a once-daily dose

Usage:

Recommended for individuals with moderate to severe hypertension, particularly those requiring combination therapy for optimal BP control.

Ideal For:

Pharmaceutical distributors, stockists, and retailers supplying hospitals, clinics, and cardiology practices looking for advanced, well-tolerated hypertension treatments.

Why Choose TELOSAF TRIO 6.25?

Manufactured under GMP-certified facilities, TELOSAF TRIO 6.25 ensures consistent quality, efficacy, and safetymaking it a reliable choice for B2B pharmaceutical partners.